Australian industry has a vital role to play in the COVID-19 response, with regard to both developing novel solutions and consolidating supply chain strength in the face of this and potential future pandemic threats. Australian industry has a critical role in ensuring supply of essential therapeutics and active pharmaceutical ingredients for vaccine and drug development. (more…)Posted by Harry Baxter on October 7th, 2020 Tagged: collaboration, Countermeasures, DMTC, DST, innovation, MCM
A new project to drive advances in hyperspectral imaging technology for defence applications has commenced.
The work is part of DMTC’s High Altitude Sensor Systems (HASS) Program. (more…)Posted by Harry Baxter on September 24th, 2020 Tagged: collaboration, DMTC, HASS, industry, innovation, technology
The challenge to develop a safe, effective and low-cost universal malaria vaccine is being tackled by a DMTC collaboration with James Cook University’s Australian Institute of Tropical Health Medicine (AITHM), Townsville Hospital, Glycosyn and Pfizer Hospira. (more…)Posted by Harry Baxter on September 4th, 2020 Tagged: collaboration, DMTC, innovation, MCM, technology
A team of researchers from Swinburne are making a vital contribution to a DMTC-managed collaboration involving a national network of research and industry partners.
The DMTC project is focused on developing a detailed understanding of the functional performance of composite materials. The specific theme of work for the Swinburne researchers, led by Dr Nishar Hameed, is novel, hybrid graphene-based multi-scale composites that can deliver advances in sensing, electromagnetic and thermal signature control for applications in the defence domain. (more…)Posted by Harry Baxter on August 20th, 2020 Tagged: defence technology, DMTC, innovation, technology